FR2438663A1 - Nouveaux steroides contraceptifs masculins et composition pharmaceutique les contenant - Google Patents

Nouveaux steroides contraceptifs masculins et composition pharmaceutique les contenant

Info

Publication number
FR2438663A1
FR2438663A1 FR7925102A FR7925102A FR2438663A1 FR 2438663 A1 FR2438663 A1 FR 2438663A1 FR 7925102 A FR7925102 A FR 7925102A FR 7925102 A FR7925102 A FR 7925102A FR 2438663 A1 FR2438663 A1 FR 2438663A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition containing
male contraceptive
contraceptive steroids
novel male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7925102A
Other languages
English (en)
Other versions
FR2438663B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2438663A1 publication Critical patent/FR2438663A1/fr
Application granted granted Critical
Publication of FR2438663B1 publication Critical patent/FR2438663B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0078—Sulfur-containing hetero ring containing only sulfur
    • C07J71/0084—Episulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE LE DOMAINE DE LA CHIMIE MEDICALE. ELLE A TRAIT A DES COMPOSES STEROIDIQUES REPONDANT, ENTRE AUTRES A LA FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE R, R, R, R, R ET R REPRESENTENT DE L'HYDROGENE OU UN RADICAL ORGANIQUE. ELLE CONCERNE EN OUTRE UNE COMPOSITION PHARMACEUTIQUE ORALE CONTENANT CES COMPOSES EN TANT QUE CONTRACEPTIFS MASCULINS.
FR7925102A 1978-10-10 1979-10-09 Nouveaux steroides contraceptifs masculins et composition pharmaceutique les contenant Granted FR2438663A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/949,797 US4297350A (en) 1978-10-10 1978-10-10 Male contraceptive steroids and methods of use

Publications (2)

Publication Number Publication Date
FR2438663A1 true FR2438663A1 (fr) 1980-05-09
FR2438663B1 FR2438663B1 (fr) 1983-06-03

Family

ID=25489549

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7925102A Granted FR2438663A1 (fr) 1978-10-10 1979-10-09 Nouveaux steroides contraceptifs masculins et composition pharmaceutique les contenant

Country Status (8)

Country Link
US (1) US4297350A (fr)
JP (1) JPS5555200A (fr)
CH (1) CH643565A5 (fr)
DE (1) DE2940132A1 (fr)
FR (1) FR2438663A1 (fr)
GB (1) GB2032924B (fr)
IT (1) IT1124568B (fr)
NL (1) NL7907317A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684636A (en) * 1985-06-24 1987-08-04 Sterling Drug Inc. Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof
US5134135A (en) * 1990-06-21 1992-07-28 Sterling Drug Inc. Antiandrogenic sulfonylsteroidooxazoles
DE4021433A1 (de) * 1990-07-04 1992-01-09 Schering Ag Antiandrogene mit steroid(3,2-c)pyrazol-struktur
WO1993007749A1 (fr) * 1991-10-23 1993-04-29 Akzo Nobel N.V. Compositions de deratisation
IL105050A0 (en) * 1992-03-27 1993-07-08 Lilly Co Eli Steroid derivatives
JP2510927B2 (ja) * 1992-06-04 1996-06-26 秩父小野田株式会社 有害物処理容器
JPH06218028A (ja) * 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
CZ394197A3 (cs) * 1995-06-06 1998-06-17 Cocensys, Inc. Neuroaktivní steroidy androstanové a pregnanové řady
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
WO2000066614A1 (fr) * 1999-04-29 2000-11-09 Purdue Pharma Ltd. Steroides substitues par heterocycle 3alpha-hydroxy-3beta-methoxymethyl-21- ayant un pouvoir anesthesique
WO2020123855A1 (fr) 2018-12-12 2020-06-18 University Of Washington Composés inhibiteurs pour contraception masculine
JP2022529745A (ja) * 2019-04-27 2022-06-23 ヘルス リサーチ インコーポレイテッド 前立腺癌の治療のためのクマリン修飾アンドロゲン

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133901A1 (fr) * 1971-04-20 1972-12-01 Syntex Corp

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052693A (en) * 1959-03-13 1962-09-04 Schering Ag Steroid alkyl ethers and process therefor
US3290293A (en) * 1961-12-01 1966-12-06 Merck & Co Inc 4-androsteno-[3, 2-c] pyrazoles
US3301850A (en) * 1964-12-01 1967-01-31 Searle & Co 17-oxygenated-5alpha-androstane-2alpha, 3alpha-episulfides
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
GB1185844A (en) * 1967-08-08 1970-03-25 Merck & Co Inc 2',3'alpha-Tetrahydrofuran-2'-Spiro-17-Androstene Compounds
US4053489A (en) * 1971-04-21 1977-10-11 Pierre Charles Wirth Oestratriene diethers
FR2210394B1 (fr) * 1972-12-19 1976-07-02 Roussel Uclaf
DE2439082A1 (de) * 1974-08-12 1976-02-26 Schering Ag 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung
FR2285138A1 (fr) * 1974-09-20 1976-04-16 Roussel Uclaf Nouveau derive steroide trienique, son procede de preparation et son application comme medicament
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
CH606101A5 (fr) * 1975-01-30 1978-10-13 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133901A1 (fr) * 1971-04-20 1972-12-01 Syntex Corp

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1967 *

Also Published As

Publication number Publication date
DE2940132A1 (de) 1980-04-24
IT7926267A0 (it) 1979-10-04
CH643565A5 (de) 1984-06-15
NL7907317A (nl) 1980-04-14
IT1124568B (it) 1986-05-07
GB2032924A (en) 1980-05-14
JPS5555200A (en) 1980-04-22
GB2032924B (en) 1982-12-22
FR2438663B1 (fr) 1983-06-03
US4297350A (en) 1981-10-27

Similar Documents

Publication Publication Date Title
FR2438663A1 (fr) Nouveaux steroides contraceptifs masculins et composition pharmaceutique les contenant
FR2442851A1 (fr) Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant
FR2506156A1 (fr) Compositions cosmetiques contenant des derives hydroxyles du dibenzoylmethane et leur utilisation pour la protection de l'epiderme humain contre les rayons ultraviolets
FR2432525A1 (fr) Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
JPS55108860A (en) Hydroxypropylltriazole*its manufacture and use as medicine
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
FR2432519A1 (fr) Nouveaux derives de purine et medicament les contenant
FR2413879A1 (fr) Agent pour lutter contre les bacteries et champignons phytopathogenes a base de nitroalcanols
FR2394546A1 (fr) Nouveaux derives de 1,2,3,4,6,7-hexahydro-11bah-benzo(a)-quinolizine, leur preparation et leur application en tant que medicaments
KR970074763A (ko) 불소화된 비타민 d₃ 유사체
ES2161201T3 (es) Derivados de benzamida, composiciones que contienen dichos derivados ysu empleo.
ZA818499B (en) Agents for combating circulatory illnesses and their use
FR2448899A1 (fr) Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2447721A1 (fr) Compositions pour le traitement du glaucome, contenant un derive de carbostyrile comme constituant actif
KR890003752A (ko) 2-피리미디닐-피페라딘 유도체의 용도
FR2395021A1 (fr) Paraphenylene diamines et compositions tinctoriales les contenant
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2416013A1 (fr) Derives d'acide (-)-(cis)-1,2-epoxypropylphosphonique, leur preparation et compositions pharmaceutiques les contenant
FR2429201A1 (fr) Sulfoxydes utilisables comme agents initiateurs de photopolymerisation
FR2437405A1 (fr) Nouveaux alcoylbenzenes substitues basiques utiles comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse